STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #4099 by analyst upside · 2026-06-27
PSNL
Personalis, Inc.
Healthcare · Market Cap $1B · P/E 0x
ANALYST PRICE TARGET
-16.6%
implied upside to consensus target
Current Price $13.02
Consensus Target $10.86
Bull Target $13.0
Bear Target $9.0
Analysts Covering 7
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
5
Hold
1
Sell
0
52-Week Low $3.84
52-Week High $13.37
YTD Return +65.9%
FUNDAMENTALS
Market Cap $1B
P/E Ratio (TTM) N/A
Forward P/E -14.5x
EPS (TTM) $-1.02
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $65M
Profit Margin -148.1%
52-WEEK RANGE
52-Week Low $3.84
52-Week High $13.37
Current Price $13.02
Bear Target $9.0
Bull Target $13.0
● Now $13.02 ● Target $10.86
TRADING DATA
Avg Volume 2.6M
YTD Return +65.9%
Analyst Count 7
Consensus Buy
Upside to Target -16.6%
Last Updated 2026-06-27

ANALYST SUMMARY

Personalis, Inc. (PSNL) is currently trading at $13.02 with a Wall Street consensus price target of $10.86, which is 16.6% below the current price over the next 12 months. 7 analysts currently cover PSNL, with a consensus rating of Buy - 86% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $13.0, while the most cautious has a target of $9.0.

PSNL operates in the Healthcare sector with a market capitalisation of $1B. The stock is up 65.9% year-to-date and is currently trading near the upper end of its 52-week range of $3.84 – $13.37.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for PSNL, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Morgan Stanley — Reiterated
Equal-Weight → Equal-Weight 2026-05-12 Building track record
BTIG — Reiterated
Buy → Buy 2026-05-11 38% win rate (8 calls)
Morgan Stanley — Reiterated
Equal-Weight → Equal-Weight 2026-03-05 Building track record
Needham — Reiterated
Buy → Buy 2026-02-27 20% win rate (5 calls)
BTIG — Reiterated
Buy → Buy 2026-02-11 38% win rate (8 calls)
Guggenheim — Reiterated
Buy → Buy 2026-01-26 62% win rate (8 calls)
BTIG reit
Buy → Buy 2026-01-09 38% win rate (8 calls)
Morgan Stanley — Reiterated
Equal-Weight → Equal-Weight 2025-12-02 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
62
out of 100
Coverage depth
16/30
Consensus clarity
24/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →